RA CAPITAL MANAGEMENT, L.P.

Holdings History for Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

Symbol: BCAX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 7,279,739 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)

02 Mar 2026 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,279,739 shares of Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX). This represents 12% ownership of the company. This is the first filing by RA CAPITAL MANAGEMENT, L.P. disclosing ownership of Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	12%		$123,100,386	7,279,739			$16.91	13D/A	26 Feb 2026	02 Mar 2026, 16:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.2%	0%	$117,069,362	6,955,993	0		$16.83	Q4 2025
30 Sep 2025	1.4%	0%	$109,835,129	6,955,993	0		$15.79	Q3 2025
30 Jun 2025	1.1%	0%	$64,621,175	6,955,993	0		$9.29	Q2 2025
31 Mar 2025	1.5%	0%	$90,636,589	6,955,993	0		$13.03	Q1 2025
31 Dec 2024	1.6%	0%	$121,173,398	6,955,993	0		$17.42	Q4 2024
30 Sep 2024	2%	+2%	$177,169,142	6,955,993	+6,955,993	NEW	$25.47	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.